Serum cholinesterase activity in burned patients. II: anaesthesia, suxamethonium and hyperkalaemia.

Serum cholinesterase activity in burned patients. I: biochemical findings.

Suxamethonium and hyperkalaemia.

Serum cholinesterase activity following enflurane anaesthesia.

Schistosomiasis, metriphonate, cholinesterase, and suxamethonium.

Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections.

Presence of suxamethonium fasciculations in patients with atypical plasma cholinesterase.

Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.

Suxamethonium sensitivity and segregation of human serum cholinesterase variants at locus, Ch1, among twelve British families.

Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.

Serum cholinesterase activity in hypothermic and posthypothermic goats.

Serum CD14 levels in polytraumatized and severely burned patients.

Change in serum cholinesterase activity in Jamaican diabetics.

Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.

Dynamic changes of serum cholinesterase activity after severe trauma.

Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury.

Predicting survival in burned patients.

Biochemical and pharmacological properties of a cardiotoxic factor isolated from the blood serum of burned patients.

Cholinesterase activity in some human lymphatic organs.

Determination of serum cholinesterase activity by liquid chromatography with electrochemical detection.

Lactate: prognostic biomarker in severely burned patients.

A third type of serum cholinesterase deficiency in Eskimos.

Glucose metabolism in severely burned patients.

The NBT test in burned patients.

Suggest Documents

Serum cholinesterase activity in burned patients. I: biochemical findings.

Suxamethonium and hyperkalaemia.

Serum cholinesterase activity following enflurane anaesthesia.

Schistosomiasis, metriphonate, cholinesterase, and suxamethonium.

Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections.

Presence of suxamethonium fasciculations in patients with atypical plasma cholinesterase.

Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase.

Suxamethonium sensitivity and segregation of human serum cholinesterase variants at locus, Ch1, among twelve British families.

Suxamethonium block in the myasthenic patient. Correlation with plasma cholinesterase.

Serum cholinesterase activity in hypothermic and posthypothermic goats.

Serum CD14 levels in polytraumatized and severely burned patients.

Change in serum cholinesterase activity in Jamaican diabetics.

Pretreatment with pancuronium before suxamethonium administration in patients heterozygous for the usual and the atypical plasma cholinesterase gene.

Dynamic changes of serum cholinesterase activity after severe trauma.

Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Serum Total Cholinesterase Activity on Admission Is Associated with Disease Severity and Outcome in Patients with Traumatic Brain Injury.

Predicting survival in burned patients.

Biochemical and pharmacological properties of a cardiotoxic factor isolated from the blood serum of burned patients.

Cholinesterase activity in some human lymphatic organs.

Determination of serum cholinesterase activity by liquid chromatography with electrochemical detection.

Lactate: prognostic biomarker in severely burned patients.

A third type of serum cholinesterase deficiency in Eskimos.

Glucose metabolism in severely burned patients.

The NBT test in burned patients.

Serum cholinesterase activity in burned patients. II: anaesthesia, suxamethonium and hyperkalaemia.

Recommend Documents

Follow Us